Posts

Showing posts with the label Pustular Psoriasis

Pustular Psoriasis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 A rare immune-mediated systemic skin condition called pustular psoriasis is characterised by yellowish pustules on an erythematous base with various clinical presentations and distribution patterns. Idiopathic pustular psoriasis is the most common type. Compared to the general population, pustular psoriasis patients have an increased frequency of the HLA-B27 allele. ·        Generalized pustular psoriasis is rare. The annual incidence and prevalence in a French population have been estimated at least 0.64 and 1.76 per million, respectively. The prevalence in Japan has been estimated at 7.46 per million.   Thelansis’s “Pustular Psoriasis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market i...

Pustular Psoriasis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
 A rare immune-mediated systemic skin condition called pustular psoriasis is characterised by yellowish pustules on an erythematous base with various clinical presentations and distribution patterns. Idiopathic pustular psoriasis is the most common type. Compared to the general population, pustular psoriasis patients have an increased frequency of the HLA-B27 allele. ·        Generalized pustular psoriasis is rare. The annual incidence and prevalence in the French population have been estimated at least 0.64 and 1.76 per million, respectively. The prevalence in Japan has been estimated at 7.46 per million. Thelansis’s “Pustular Psoriasis Market Outlook, Epidemiology , Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insigh...

Pustular Psoriasis – Market outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030

Image
Pustular psoriasis is a rare, immune-mediated systemic skin disorder characterized by yellowish pustules on an erythematous base with a variety of clinical presentations and distribution patterns. Etiology- Patients with pustular psoriasis have an increased frequency of the HLA-B27 allele compared to the general population. Most cases of pustular psoriasis are idiopathic. Epidemiology- Generalized pustular psoriasis is rare. The annual incidence and prevalence in a French population have been estimated at least 0.64 and 1.76 per million, respectively. The prevalence in Japan has been estimated at 7.46 per million. The competitive landscape of Pustular Psoriasis includes country-specific approved and pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are tracked and supplemented with analyst commentary. KOLs insights of Pustular Psoriasis across 8 MM market from the center of Excellence/ Public/ Private hospitals participated in the study. Ins...